The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-13 of 13 articles
Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis
Coughlan J,
Aytekin A,
Lahu S,
Scalamogna M,
Wiebe J,
Pinieck S,
Kufner S,
Xhepa E,
Joner M,
Kuna C,
Voll F,
Laugwitz K,
Schunkert H,
Kastrati A,
Cassese S
April 3, 2023 | 10.4244/EIJ-D-22-00860
Ten-year clinical outcomes of drug-eluting stents with different polymer coating strategies by degree of coronary calcification: a pooled analysis of the ISAR-TEST 4 and 5 randomised trials
Rheude T,
Koch T,
Joner M,
Lenz T,
Xhepa E,
Wiebe J,
Coughlan J,
Aytekin A,
Cassese S,
Laugwitz K,
Schunkert H,
Kastrati A,
Kufner S
February 20, 2023 | 10.4244/EIJ-D-22-00781
Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial
Wiebe J,
Byrne RA,
Alfonso F,
Maeng M,
Bradaric C,
Kretov E,
Cuesta J,
Kuna C,
Ibrahim T,
Rivero F,
Heugl M,
Christiansen E,
Joner M,
Schunkert H,
Laugwitz K,
Kastrati A,
Cassese S
March 18, 2022 | 10.4244/EIJ-D-21-00653
Outcomes of rotational atherectomy versus modified balloon angioplasty in severely calcified coronary lesions based on target lesion location: a post hoc analysis of the PREPARE-CALC randomised trial
Rheude T,
Toelg R,
Byrne RA,
Allali A,
Wiebe J,
Sulimov D,
Voll F,
Cassese S,
Richardt G,
Kastrati A,
Abdel-Wahab M
July 17, 2020 | 10.4244/EIJ-D-19-00488
Predictors of haemodynamic structural valve deterioration following transcatheter aortic valve implantation with latest-generation balloon-expandable valves
Rheude T,
Pellegrini C,
Cassese S,
Wiebe J,
Wagner S,
Trenkwalder T,
Alvarez H,
Mayr P,
Hengstenberg C,
Schunkert H,
Kastrati A,
Husser O,
Joner M
February 20, 2020 | 10.4244/EIJ-D-19-00710
Sex and long-term outcomes after implantation of the Absorb bioresorbable vascular scaffold for treatment of coronary artery disease
Baquet M,
Hoppmann P,
Grundmann D,
Schmidt W,
Kufner S,
Theiss H,
Brunner S,
Wiebe J,
Eickhoff M,
Jochheim D,
Byrne RA,
Laugwitz K,
Schunkert H,
Massberg S,
Kastrati A,
Mehilli J
September 20, 2019 | 10.4244/EIJ-D-18-00603
Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)
Nef H,
Wiebe J,
Kastner J,
Mehilli J,
Munzel T,
Naber C,
Neumann T,
Richardt G,
Schmermund A,
Wöhrle J,
Zahn R,
Riemer T,
Achenbach S,
Hamm C
December 20, 2017 | 10.4244/EIJ-D-17-00330
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry
Schnorbus B,
Wiebe J,
Capodanno D,
Brugaletta S,
Geraci S,
Mehilli J,
Latib A,
Lesiak M,
Jensen C,
Mattesini A,
Munzel T,
Capranzano P,
Di Mario C,
Naber C,
Araszkiewicz A,
Colombo A,
Caramanno G,
Sabaté M,
Tamburino C,
Nef H,
Gori T
October 11, 2017 | 10.4244/EIJ-D-16-00568
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score
Ortega-Paz L,
Capodanno D,
Gori T,
Nef H,
Latib A,
Caramanno G,
Di Mario C,
Naber C,
Lesiak M,
Capranzano P,
Wiebe J,
Mehilli J,
Araszkiewicz A,
Pyxaras S,
Mattesini A,
Geraci S,
Naganuma T,
Colombo A,
Munzel T,
Sabaté M,
Tamburino C,
Brugaletta S
April 20, 2017 | 10.4244/EIJ-D-16-00974
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry
Gori T,
Wiebe J,
Capodanno D,
Latib A,
Lesiak M,
Pyxaras S,
Mehilli J,
Caramanno G,
Di Mario C,
Brugaletta S,
Weber J,
Capranzano P,
Sabaté M,
Mattesini A,
Geraci S,
Naber C,
Araszkiewicz A,
Colombo A,
Tamburino C,
Nef H,
Munzel T
August 5, 2016 | 10.4244/EIJY15M09_10
Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry
Wiebe J,
Hoppmann P,
Kufner S,
Harada Y,
Colleran R,
Michel J,
Giacoppo D,
Schneider S,
Cassese S,
Ibrahim T,
Schunkert H,
Laugwitz K,
Kastrati A,
Byrne RA
June 10, 2016 | 10.4244/EIJY16M05_03
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry
Capodanno D,
Gori T,
Nef H,
Latib A,
Mehilli J,
Lesiak M,
Caramanno G,
Naber C,
Di Mario C,
Colombo A,
Capranzano P,
Wiebe J,
Araszkiewicz A,
Geraci S,
Pyxaras S,
Mattesini A,
Naganuma T,
Munzel T,
Tamburino C
February 20, 2015 | 10.4244/EIJY14M07_11
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023